SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-010283
Filing Date
2023-02-10
Accepted
2023-02-10 16:05:18
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 3223
  Complete submission text file 0001213900-23-010283.txt   4790
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS,INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Shefferman Jesse (Reporting) CIK: 0001799167 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36694 | Film No.: 23611766